Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19
Condition(s):Respiratory Distress Syndrome, Adult; COVID-19Last Updated:August 12, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Respiratory Distress Syndrome, Adult; COVID-19Last Updated:August 12, 2021Terminated
Condition(s):Respiratory Distress SyndromeLast Updated:June 6, 2017Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:July 2, 2021Completed
Condition(s):RDS; Infant, Newborn; Vitamin A; SurfactantLast Updated:July 26, 2011Unknown status
Condition(s):Neonatal Respiratory Distress SyndromeLast Updated:February 28, 2019Completed
Condition(s):Acute Lung Injury; Acute Respiratory Distress SyndromeLast Updated:February 5, 2021Completed
Condition(s):Acute Lung InjuryLast Updated:May 27, 2015Completed
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:February 10, 2017Terminated
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:January 17, 2024Completed
Condition(s):Acute Lung InjuryLast Updated:February 29, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.